Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-21

Clinical Trial Update: Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing ethosuximide for peripheral neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethosuximide (ethosuximide)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Neuropathic Traumatic Pain, Pain NRS ≥ 4 | Phase 2 | Status: COMPLETED